February 28, 2019 RARE DISEASE DAY 2019 Rare Disease Day 2019 was marked on February 28 around the world and at the NIH with a special day filled with opportunities to meet wonderful people committed to making … Read more
January 18, 2019 LILLY REPORTS RESULTS OF PHASE 3 SOFT TISSUE SARCOMA Today, Eli Lilly reported that the results of their Phase 3 study of olaratumab (LARTRUVO®) in combination with doxorubicin versus doxorubicin alone in patients with advanced or metastatic soft tissue … Read more